Related Experiment Videos
Clot lipids in ischaemic heart disease
Insights
Patients with ischemic heart disease show elevated triglycerides (TG) bound to blood clots. This suggests increased binding of TG-rich lipoproteins to clots, potentially impacting clot volume and fibrinolysis, contributing to heart disease pathogenesis.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Hemostasis and Thrombosis
Background:
- Coronary artery disease (CAD) and acute myocardial infarction (AMI) are significant cardiovascular diseases.
- The role of lipid composition within blood clots in the pathogenesis of ischemic heart disease is not fully understood.
Purpose of the Study:
- To investigate the lipid composition of plasma, HDL, and clots in patients with CAD and AMI compared to healthy subjects.
- To determine the relationship between clot lipid content and coagulation parameters in ischemic heart disease.
Main Methods:
- Analysis of total phospholipids (PL) and neutral lipid classes in plasma and HDL.
- Determination of coagulation parameters.
- Quantification of lipids within clots formed from platelet-rich plasma.
Main Results:
- Plasma and HDL lipid profiles, along with main coagulation parameters, showed no significant differences between groups.
- A selective elevation of triglycerides (TG) bound to clots was observed in patients with ischemic heart disease (AMI and CAD).
- This suggests enhanced binding of TG-rich lipoproteins to clots, rather than passive trapping.
Conclusions:
- Elevated clot-bound triglycerides in ischemic heart disease patients indicate increased lipoprotein-clot interaction.
- These alterations in clot composition may increase clot volume and impede fibrinolysis.
- This finding has potential significance in the pathogenesis of ischemic heart disease.
Abstract:
Total phospholipids (PL) and neutral lipid classes of plasma, of HDL and of clots produced from platelet-rich plasma and also the main coagulation parameters were determined in normal subjects and in patients with acute myocardial infarction (AMI) and with angiographically diagnosed coronary artery disease (CAD). The main plasma and HDL lipid fractions and the coagulation parameters did not differ significantly between the groups. In contrast, in both groups with ischaemic heart disease triglycerides (TG) bound to clots were selectively elevated precluding accidental trapping of lipoproteins in the fibrin network and suggesting an increased binding of TG-rich lipoproteins to clots. These changes in the quantity and quality of platelet-rich clots, resembling platelet-rich thrombi in vivo, might not only increase the volume of the clots, but also inhibit fibrinolytic enzymes from reaching their substrate. This might be significant in the pathogenesis of ischaemic heart disease.